Inactive Ingredient Search for Approved Drug Products
Search Names Beginning with d
| Inactive Ingredient | Route | Dosage Form | CAS Number | UNII | Maximum Potency per unit dose | Maximum Daily Exposure (MDE) | Record Updated |
|---|---|---|---|---|---|---|---|
| D&C BLUE NO. 1 LAKE | ORAL | TABLET | NA | 15.4mg | |||
| D&C BLUE NO. 1 LAKE | ORAL | TABLET, COATED | NA | NA | |||
| D&C BLUE NO. 1--ALUMINUM LAKE | ORAL | TABLET | NA | 3.6mg | |||
| D&C BLUE NO. 1--ALUMINUM LAKE | ORAL | TABLET, COATED | NA | NA | |||
| D&C BLUE NO. 1--ALUMINUM LAKE | ORAL | TABLET, FILM COATED | NA | 1mg | |||
| D&C BLUE NO. 2 LAKE | ORAL | CAPSULE | NA | NA | |||
| D&C BLUE NO. 2 LAKE | ORAL | TABLET | NA | 0.24mg | |||
| D&C BLUE NO. 2 LAKE | ORAL | TABLET, COATED | NA | 0.01mg | |||
| D&C GREEN NO. 3 LAKE | ORAL | CAPSULE | NA | NA | |||
| D&C GREEN NO. 3 LAKE | ORAL | TABLET, COATED | NA | NA | |||
| D&C GREEN NO. 5 | ORAL | CAPSULE, EXTENDED RELEASE | 4403901 | 8J6RDU8L9X | NA | ||
| D&C GREEN NO. 5 | ORAL | SOLUTION | 4403901 | 8J6RDU8L9X | NA | ||
| D&C GREEN NO. 5 | ORAL | TABLET | 4403901 | 8J6RDU8L9X | 0.03mg | ||
| D&C GREEN NO. 5 | ORAL | TABLET, COATED | 4403901 | 8J6RDU8L9X | NA | ||
| D&C GREEN NO. 5 | TOPICAL | SHAMPOO | 4403901 | 8J6RDU8L9X | 0.09%w/w | ||
| D&C GREEN NO. 5 | TOPICAL | SOAP | 4403901 | 8J6RDU8L9X | NA | ||
| D&C RED NO. 21--ALUMINUM LAKE | ORAL | CAPSULE | NA | NA | |||
| D&C RED NO. 21--ALUMINUM LAKE | ORAL | TABLET, CHEWABLE | NA | NA | |||
| D&C RED NO. 22 | ORAL | CAPSULE | 17372871 | 1678RKX8RT | 0.02mg | ||
| D&C RED NO. 22 | ORAL | CAPSULE, EXTENDED RELEASE | 17372871 | 1678RKX8RT | NA | ||
| D&C RED NO. 22 | ORAL | SUSPENSION | 17372871 | 1678RKX8RT | NA | ||
| D&C RED NO. 22 | ORAL | TABLET, COATED | 17372871 | 1678RKX8RT | NA | ||
| D&C RED NO. 22 | ORAL | TABLET, DELAYED RELEASE | 17372871 | 1678RKX8RT | 0.38mg | ||
| D&C RED NO. 27 | ORAL | POWDER, FOR SUSPENSION | 13473262 | 2LRS185U6K | 1.67mg/5ml | ||
| D&C RED NO. 27 | ORAL | TABLET | 13473262 | 2LRS185U6K | 2mg | ||
| D&C RED NO. 27 | ORAL | TABLET, CHEWABLE | 13473262 | 2LRS185U6K | 2mg | ||
| D&C RED NO. 27 | ORAL | TABLET, DELAYED RELEASE | 13473262 | 2LRS185U6K | 1mg | ||
| D&C RED NO. 27 | ORAL | TABLET, EXTENDED RELEASE | 13473262 | 2LRS185U6K | 1.43mg | ||
| D&C RED NO. 27 ALUMINUM LAKE | ORAL | CAPSULE | 15876581 | ZK64F7XSTX | 1.31mg | ||
| D&C RED NO. 27 ALUMINUM LAKE | ORAL | TABLET | 15876581 | ZK64F7XSTX | 1mg | ||
| D&C RED NO. 27 ALUMINUM LAKE | ORAL | TABLET, CHEWABLE | 15876581 | ZK64F7XSTX | 2.5mg | ||
| D&C RED NO. 27 ALUMINUM LAKE | ORAL | TABLET, DELAYED RELEASE | 15876581 | ZK64F7XSTX | 0.6mg | ||
| D&C RED NO. 27 ALUMINUM LAKE | ORAL | TABLET, EXTENDED RELEASE | 15876581 | ZK64F7XSTX | 0.54mg | ||
| D&C RED NO. 27 ALUMINUM LAKE | ORAL | TABLET, FILM COATED | 15876581 | ZK64F7XSTX | NA | ||
| D&C RED NO. 27 ALUMINUM LAKE | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 15876581 | ZK64F7XSTX | NA | ||
| D&C RED NO. 27 LAKE | ORAL | CAPSULE, EXTENDED RELEASE | NA | NA | |||
| D&C RED NO. 27 LAKE | ORAL | TABLET | NA | 0.4mg | |||
| D&C RED NO. 28 | ORAL | CAPSULE | 18472872 | 767IP0Y5NH | 1mg | ||
| D&C RED NO. 28 | ORAL | CAPSULE, COATED PELLETS | 18472872 | 767IP0Y5NH | NA | ||
| D&C RED NO. 28 | ORAL | CAPSULE, COATED, EXTENDED RELEASE | 18472872 | 767IP0Y5NH | NA | ||
| D&C RED NO. 28 | ORAL | CAPSULE, DELAYED RELEASE | 18472872 | 767IP0Y5NH | 1mg | ||
| D&C RED NO. 28 | ORAL | CAPSULE, EXTENDED RELEASE | 18472872 | 767IP0Y5NH | 0.2mg | ||
| D&C RED NO. 28 | ORAL | POWDER, FOR SOLUTION | 18472872 | 767IP0Y5NH | 3mg | ||
| D&C RED NO. 28 | ORAL | POWDER, FOR SUSPENSION | 18472872 | 767IP0Y5NH | 0.7mg/5ml | ||
| D&C RED NO. 28 | ORAL | SUSPENSION | 18472872 | 767IP0Y5NH | 2.5mg/5ml | ||
| D&C RED NO. 28 | ORAL | TABLET | 18472872 | 767IP0Y5NH | NA | ||
| D&C RED NO. 28 | TOPICAL | AEROSOL | 18472872 | 767IP0Y5NH | NA | ||
| D&C RED NO. 28 | TOPICAL | SOAP | 18472872 | 767IP0Y5NH | NA | ||
| D&C RED NO. 28--ALUMINUM LAKE | ORAL | CAPSULE | NA | NA | |||
| D&C RED NO. 28--ALUMINUM LAKE | ORAL | TABLET | NA | 0.11mg | |||
| D&C RED NO. 30 | ORAL | CAPSULE | 52641313 | 2S42T2808B | 0.1mg | ||
| D&C RED NO. 30 | ORAL | TABLET | 52641313 | 2S42T2808B | 19mg | ||
| D&C RED NO. 30 | ORAL | TABLET, CHEWABLE | 52641313 | 2S42T2808B | 3mg | ||
| D&C RED NO. 30 | ORAL | TABLET, CHEWABLE, EXTENDED RELEASE | 52641313 | 2S42T2808B | 1mg | ||
| D&C RED NO. 30 | ORAL | TABLET, COATED | 52641313 | 2S42T2808B | 1.16mg | ||
| D&C RED NO. 30 | ORAL | TABLET, DELAYED RELEASE | 52641313 | 2S42T2808B | NA | ||
| D&C RED NO. 30 | ORAL | TABLET, EXTENDED RELEASE | 52641313 | 2S42T2808B | 0.22mg | ||
| D&C RED NO. 30 | ORAL | TABLET, FILM COATED | 52641313 | 2S42T2808B | 0.26mg | ||
| D&C RED NO. 30 ALUMINUM LAKE | ORAL | CAPSULE | NA | NA | |||
| D&C RED NO. 30 ALUMINUM LAKE | ORAL | CAPSULE, DELAYED RELEASE | NA | 0.3mg | |||
| D&C RED NO. 30 ALUMINUM LAKE | ORAL | GRANULE, FOR SUSPENSION | NA | 0.85mg/5ml | |||
| D&C RED NO. 30 ALUMINUM LAKE | ORAL | POWDER | NA | 3mg | |||
| D&C RED NO. 30 ALUMINUM LAKE | ORAL | SUSPENSION | NA | 1mg | |||
| D&C RED NO. 30 ALUMINUM LAKE | ORAL | SUSPENSION, EXTENDED RELEASE | NA | 7mg | |||
| D&C RED NO. 30 ALUMINUM LAKE | ORAL | TABLET | NA | 30mg | |||
| D&C RED NO. 30 ALUMINUM LAKE | ORAL | TABLET, CHEWABLE | NA | 5mg | |||
| D&C RED NO. 30 ALUMINUM LAKE | ORAL | TABLET, COATED | NA | 5mg | |||
| D&C RED NO. 30 ALUMINUM LAKE | ORAL | TABLET, DELAYED RELEASE | NA | 0.04mg | |||
| D&C RED NO. 30 ALUMINUM LAKE | ORAL | TABLET, EXTENDED RELEASE | NA | 0.1mg | |||
| D&C RED NO. 30 ALUMINUM LAKE | ORAL | TABLET, FILM COATED | NA | 0.3mg | |||
| D&C RED NO. 30 ALUMINUM LAKE | ORAL | WAFER | NA | 0.9mg | |||
| D&C RED NO. 33 | DENTAL | SOLUTION | 3567666 | 9DBA0SBB0L | NA | ||
| D&C RED NO. 33 | ORAL | CAPSULE | 3567666 | 9DBA0SBB0L | 1mg | ||
| D&C RED NO. 33 | ORAL | CAPSULE, EXTENDED RELEASE | 3567666 | 9DBA0SBB0L | NA | ||
| D&C RED NO. 33 | ORAL | CAPSULE, LIQUID FILLED | 3567666 | 9DBA0SBB0L | 0.01mg | ||
| D&C RED NO. 33 | ORAL | CONCENTRATE | 3567666 | 9DBA0SBB0L | 0.02mg/1ml | ||
| D&C RED NO. 33 | ORAL | ELIXIR | 3567666 | 9DBA0SBB0L | 27.5mg/5ml | ||
| D&C RED NO. 33 | ORAL | SOLUTION | 3567666 | 9DBA0SBB0L | 2mg | ||
| D&C RED NO. 33 | ORAL | SUSPENSION | 3567666 | 9DBA0SBB0L | 0.13mg/5ml | ||
| D&C RED NO. 33 | ORAL | SUSPENSION, EXTENDED RELEASE | 3567666 | 9DBA0SBB0L | NA | ||
| D&C RED NO. 33 | ORAL | SYRUP | 3567666 | 9DBA0SBB0L | 0.1mg | ||
| D&C RED NO. 33 | ORAL | TABLET | 3567666 | 9DBA0SBB0L | 0.24mg | ||
| D&C RED NO. 33 | ORAL | TABLET, COATED | 3567666 | 9DBA0SBB0L | NA | ||
| D&C RED NO. 33 | ORAL | TABLET, FILM COATED | 3567666 | 9DBA0SBB0L | NA | ||
| D&C RED NO. 33 | TOPICAL | SHAMPOO | 3567666 | 9DBA0SBB0L | NA | ||
| D&C RED NO. 33 LAKE | ORAL | CAPSULE | NA | NA | |||
| D&C RED NO. 33 LAKE | ORAL | TABLET | NA | 0.3mg | |||
| D&C RED NO. 36 | ORAL | TABLET | 2814779 | OE8ZA0KN9Z | 48.75mg | ||
| D&C RED NO. 40 LAKE | ORAL | CAPSULE | NA | NA | |||
| D&C RED NO. 40 LAKE | ORAL | CAPSULE, EXTENDED RELEASE | NA | NA | |||
| D&C RED NO. 40 LAKE | ORAL | TABLET | NA | 0.15mg | |||
| D&C RED NO. 40 LAKE | ORAL | TABLET, COATED | NA | NA | |||
| D&C RED NO. 40 LAKE | RECTAL | SUPPOSITORY | NA | NA | |||
| D&C RED NO. 6 | ORAL | TABLET, COATED | 5858811 | 481744AI4O | NA | ||
| D&C RED NO. 6 | ORAL | TABLET, EXTENDED RELEASE | 5858811 | 481744AI4O | 0.2mg | ||
| D&C RED NO. 6 BARIUM LAKE | ORAL | TABLET | 17852981 | K4XZD9W99K | 0.38mg | ||
| D&C RED NO. 6 LAKE | ORAL | TABLET | NA | 1.5mg | |||
| D&C RED NO. 6 LAKE | ORAL | TABLET, EXTENDED RELEASE | NA | 0.13mg | |||
| D&C RED NO. 7 | ORAL | CAPSULE | 5281049 | ECW0LZ41X8 | NA | ||
| D&C RED NO. 7 | ORAL | CAPSULE, DELAYED RELEASE | 5281049 | ECW0LZ41X8 | NA | ||
| D&C RED NO. 7 | ORAL | TABLET | 5281049 | ECW0LZ41X8 | 0.5mg | ||
| D&C RED NO. 7 | ORAL | TABLET, CHEWABLE, EXTENDED RELEASE | 5281049 | ECW0LZ41X8 | 0.4mg | ||
| D&C RED NO. 7 | ORAL | TABLET, COATED | 5281049 | ECW0LZ41X8 | NA | ||
| D&C RED NO. 7 | ORAL | TABLET, EXTENDED RELEASE | 5281049 | ECW0LZ41X8 | NA | ||
| D&C RED NO. 7 | ORAL | TABLET, FILM COATED | 5281049 | ECW0LZ41X8 | 2mg | Y | |
| D&C RED NO. 7 | SUBLINGUAL | TABLET | 5281049 | ECW0LZ41X8 | 0.01mg | ||
| D&C RED NO. 7 LAKE | ORAL | CAPSULE | NA | NA | |||
| D&C RED NO. 7 LAKE | ORAL | TABLET | NA | 0.6mg | |||
| D&C RED NO. 7 LAKE | ORAL | TABLET, DELAYED RELEASE | NA | 0.5mg | |||
| D&C RED NO. 7 LAKE | ORAL | TABLET, FILM COATED | NA | NA | |||
| D&C YELLOW NO. 10 | BUCCAL | GUM, CHEWING | 8004920 | 35SW5USQ3G | 21mg | ||
| D&C YELLOW NO. 10 | DENTAL | GEL | 8004920 | 35SW5USQ3G | NA | ||
| D&C YELLOW NO. 10 | DENTAL | PASTE | 8004920 | 35SW5USQ3G | NA | ||
| D&C YELLOW NO. 10 | ORAL | CAPSULE | 8004920 | 35SW5USQ3G | 20mg | ||
| D&C YELLOW NO. 10 | ORAL | CAPSULE, COATED PELLETS | 8004920 | 35SW5USQ3G | 0.01mg | ||
| D&C YELLOW NO. 10 | ORAL | CAPSULE, DELAYED RELEASE | 8004920 | 35SW5USQ3G | 1mg | ||
| D&C YELLOW NO. 10 | ORAL | CAPSULE, EXTENDED RELEASE | 8004920 | 35SW5USQ3G | 3mg | ||
| D&C YELLOW NO. 10 | ORAL | CAPSULE, LIQUID FILLED | 8004920 | 35SW5USQ3G | 1.51mg | ||
| D&C YELLOW NO. 10 | ORAL | CONCENTRATE | 8004920 | 35SW5USQ3G | 0.03mg/1ml | ||
| D&C YELLOW NO. 10 | ORAL | ELIXIR | 8004920 | 35SW5USQ3G | 0.3mg/15ml | ||
| D&C YELLOW NO. 10 | ORAL | GUM, CHEWING | 8004920 | 35SW5USQ3G | 0.1mg | ||
| D&C YELLOW NO. 10 | ORAL | LIQUID | 8004920 | 35SW5USQ3G | NA | ||
| D&C YELLOW NO. 10 | ORAL | POWDER | 8004920 | 35SW5USQ3G | 6mg | ||
| D&C YELLOW NO. 10 | ORAL | POWDER, FOR SOLUTION | 8004920 | 35SW5USQ3G | NA | ||
| D&C YELLOW NO. 10 | ORAL | POWDER, FOR SUSPENSION | 8004920 | 35SW5USQ3G | 76mg | ||
| D&C YELLOW NO. 10 | ORAL | SOLUTION | 8004920 | 35SW5USQ3G | 8mg | ||
| D&C YELLOW NO. 10 | ORAL | SUSPENSION | 8004920 | 35SW5USQ3G | 20mg/5ml | ||
| D&C YELLOW NO. 10 | ORAL | SUSPENSION, EXTENDED RELEASE | 8004920 | 35SW5USQ3G | 0.3mg/5ml | ||
| D&C YELLOW NO. 10 | ORAL | SYRUP | 8004920 | 35SW5USQ3G | 2mg | ||
| D&C YELLOW NO. 10 | ORAL | TABLET | 8004920 | 35SW5USQ3G | 80mg | ||
| D&C YELLOW NO. 10 | ORAL | TABLET, CHEWABLE | 8004920 | 35SW5USQ3G | 4mg | ||
| D&C YELLOW NO. 10 | ORAL | TABLET, COATED | 8004920 | 35SW5USQ3G | 2.5mg | ||
| D&C YELLOW NO. 10 | ORAL | TABLET, DELAYED RELEASE | 8004920 | 35SW5USQ3G | 1.9mg | ||
| D&C YELLOW NO. 10 | ORAL | TABLET, EXTENDED RELEASE | 8004920 | 35SW5USQ3G | 14mg | ||
| D&C YELLOW NO. 10 | ORAL | TABLET, FILM COATED | 8004920 | 35SW5USQ3G | 120mg | ||
| D&C YELLOW NO. 10 | RECTAL | SOLUTION | 8004920 | 35SW5USQ3G | NA | ||
| D&C YELLOW NO. 10 | RECTAL | SUPPOSITORY | 8004920 | 35SW5USQ3G | 0.11mg | ||
| D&C YELLOW NO. 10 | SUBLINGUAL | TABLET | 8004920 | 35SW5USQ3G | 0.23mg | ||
| D&C YELLOW NO. 10 | TOPICAL | GEL | 8004920 | 35SW5USQ3G | NA | ||
| D&C YELLOW NO. 10 | TOPICAL | LOTION | 8004920 | 35SW5USQ3G | NA | ||
| D&C YELLOW NO. 10 | TOPICAL | SHAMPOO | 8004920 | 35SW5USQ3G | NA | ||
| D&C YELLOW NO. 10 | TOPICAL | SOAP | 8004920 | 35SW5USQ3G | 1.4%w/w | ||
| D&C YELLOW NO. 10 ALUMINUM LAKE | BUCCAL | GUM, CHEWING | 68814040 | CQ3XH3DET6 | 40mg | ||
| D&C YELLOW NO. 10 ALUMINUM LAKE | ORAL | CAPSULE | 68814040 | CQ3XH3DET6 | 1.2mg | ||
| D&C YELLOW NO. 10 ALUMINUM LAKE | ORAL | CAPSULE, COATED, EXTENDED RELEASE | 68814040 | CQ3XH3DET6 | NA | ||
| D&C YELLOW NO. 10 ALUMINUM LAKE | ORAL | CAPSULE, DELAYED RELEASE | 68814040 | CQ3XH3DET6 | 0.3mg | ||
| D&C YELLOW NO. 10 ALUMINUM LAKE | ORAL | CAPSULE, EXTENDED RELEASE | 68814040 | CQ3XH3DET6 | 1.24mg | ||
| D&C YELLOW NO. 10 ALUMINUM LAKE | ORAL | POWDER | 68814040 | CQ3XH3DET6 | 240mg | Y | |
| D&C YELLOW NO. 10 ALUMINUM LAKE | ORAL | POWDER, FOR SUSPENSION | 68814040 | CQ3XH3DET6 | 258mg | ||
| D&C YELLOW NO. 10 ALUMINUM LAKE | ORAL | SOLUTION | 68814040 | CQ3XH3DET6 | 0.09mg/5ml | ||
| D&C YELLOW NO. 10 ALUMINUM LAKE | ORAL | SUSPENSION | 68814040 | CQ3XH3DET6 | 7mg | ||
| D&C YELLOW NO. 10 ALUMINUM LAKE | ORAL | TABLET | 68814040 | CQ3XH3DET6 | 25mg | ||
| D&C YELLOW NO. 10 ALUMINUM LAKE | ORAL | TABLET, CHEWABLE | 68814040 | CQ3XH3DET6 | 3mg | ||
| D&C YELLOW NO. 10 ALUMINUM LAKE | ORAL | TABLET, COATED | 68814040 | CQ3XH3DET6 | 3.68mg | ||
| D&C YELLOW NO. 10 ALUMINUM LAKE | ORAL | TABLET, DELAYED RELEASE | 68814040 | CQ3XH3DET6 | 0.05mg | ||
| D&C YELLOW NO. 10 ALUMINUM LAKE | ORAL | TABLET, EXTENDED RELEASE | 68814040 | CQ3XH3DET6 | 28mg | ||
| D&C YELLOW NO. 10 ALUMINUM LAKE | ORAL | TABLET, FILM COATED | 68814040 | CQ3XH3DET6 | 6mg | ||
| D&C YELLOW NO. 10 ALUMINUM LAKE | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 68814040 | CQ3XH3DET6 | 0.8mg | ||
| D&C YELLOW NO. 10 ALUMINUM LAKE | ORAL | TABLET, FOR SUSPENSION | 68814040 | CQ3XH3DET6 | 0.13mg | ||
| D&C YELLOW NO. 10 ALUMINUM LAKE | ORAL | TABLET, ORALLY DISINTEGRATING | 68814040 | CQ3XH3DET6 | 2.08mg | ||
| D&C YELLOW NO. 10 ALUMINUM LAKE | SUBLINGUAL | TABLET | 68814040 | CQ3XH3DET6 | 0.18mg | ||
| D&C YELLOW NO. 10 ALUMINUM LAKE | TOPICAL | SOLUTION | 68814040 | CQ3XH3DET6 | NA | ||
| D&C YELLOW NO. 6 LAKE | ORAL | CAPSULE | NA | NA | |||
| D&C YELLOW NO. 6 LAKE | ORAL | CAPSULE, COATED PELLETS | NA | 0.5mg | |||
| D&C YELLOW NO. 6 LAKE | ORAL | CAPSULE, EXTENDED RELEASE | NA | 1.3mg | |||
| D&C YELLOW NO. 6 LAKE | ORAL | SOLUTION | NA | 0.25mg/5ml | |||
| D&C YELLOW NO. 6 LAKE | ORAL | TABLET | NA | 0.5mg | |||
| D&C YELLOW NO. 6 LAKE | ORAL | TABLET, COATED | NA | NA | |||
| D&C YELLOW NO. 6 LAKE | ORAL | TABLET, EXTENDED RELEASE | NA | 5.35mg | |||
| D&C YELLOW NO. 6 LAKE | ORAL | TABLET, FILM COATED | NA | NA | |||
| D&C YELLOW NO. 6 LAKE | SUBLINGUAL | TABLET | NA | 0.01mg | |||
| DC ANTIFOAM AF TRITURATION 1% ON SUCROSE | ORAL | POWDER, FOR SOLUTION | NA | 2.63mg/1ml | |||
| DEHYDAG WAX SX | ORAL | TABLET, COATED | 8023403 | NA | NA | ||
| DEHYDAG WAX SX | TOPICAL | CREAM | 8023403 | NA | 8.5%w/w | ||
| DEHYDROACETIC ACID | TOPICAL | LOTION | 520456 | 2KAG279R6R | 0.1%w/w | ||
| DEHYDROACETIC ACID | TOPICAL | SHAMPOO | 520456 | 2KAG279R6R | NA | ||
| DEHYMULS E | TOPICAL | OINTMENT | NA | 7.5%w/w | |||
| DENATONIUM BENZOATE | TOPICAL | GEL | 86398530 | 4YK5Z54AT2 | NA | ||
| DENATONIUM BENZOATE | TOPICAL | SOLUTION | 86398530 | 4YK5Z54AT2 | NA | ||
| DENATONIUM BENZOATE | TOPICAL | SWAB | 86398530 | 4YK5Z54AT2 | NA | ||
| DETOSU/TRIETHYLENE GLYCOL/TRIETHYLENE GLYCOL POLYGLYCOLIDE COPOLYMER | SUBCUTANEOUS | INJECTION | JC2Q67KRW7 | 392mg | |||
| DEXTRAN | OPHTHALMIC | SOLUTION/ DROPS | 9004540 | NA | 20%w/w | ||
| DEXTRAN 40 | INTRAVENOUS | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | 9004540 | K3R6ZDH4DU | 300mg | ||
| DEXTRATES | ORAL | LOZENGE | G263MI44RU | 598.8mg | |||
| DEXTRATES | ORAL | POWDER | G263MI44RU | 2567mg | |||
| DEXTRATES | ORAL | TABLET | G263MI44RU | 437mg | |||
| DEXTRATES | ORAL | TABLET, CHEWABLE | G263MI44RU | 6398mg | |||
| DEXTRATES | ORAL | TABLET, EXTENDED RELEASE | G263MI44RU | 594mg | |||
| DEXTRATES | ORAL | TABLET, ORALLY DISINTEGRATING | G263MI44RU | 311mg | |||
| DEXTRATES | ORAL | TROCHE | G263MI44RU | 4505mg | |||
| DEXTRATES | TRANSMUCOSAL | LOZENGE | G263MI44RU | 1840mg | |||
| DEXTRINS MODIFIED | ORAL | TABLET | NA | NA | |||
| DEXTROSE | BUCCAL | LOZENGE | IY9XDZ35W2 | NA | |||
| DEXTROSE | INTRAMUSCULAR | INJECTION | IY9XDZ35W2 | 5%w/v | |||
| DEXTROSE | INTRAMUSCULAR | INJECTION, POWDER, FOR SOLUTION | IY9XDZ35W2 | 1600mg | |||
| DEXTROSE | INTRASPINAL | INJECTION | IY9XDZ35W2 | 75mg | |||
| DEXTROSE | INTRATHECAL | INJECTION, SOLUTION | IY9XDZ35W2 | 1925mg | |||
| DEXTROSE | INTRAVENOUS | INJECTION | IY9XDZ35W2 | 1450mg | |||
| DEXTROSE | INTRAVENOUS | INJECTION, POWDER, FOR SOLUTION | IY9XDZ35W2 | 30144mg | |||
| DEXTROSE | INTRAVENOUS | INJECTION, SOLUTION | IY9XDZ35W2 | 51.7mg | |||
| DEXTROSE | INTRAVENOUS | POWDER, FOR SOLUTION | IY9XDZ35W2 | 5.02%w/v | |||
| DEXTROSE | INTRAVENOUS | SOLUTION | IY9XDZ35W2 | 5.05%w/v | |||
| DEXTROSE | NASAL | SPRAY | IY9XDZ35W2 | 200mg | |||
| DEXTROSE | NASAL | SPRAY, METERED | IY9XDZ35W2 | 50mg | |||
| DEXTROSE | ORAL | CAPSULE, DELAYED RELEASE | IY9XDZ35W2 | 2mg | |||
| DEXTROSE | ORAL | CONCENTRATE | IY9XDZ35W2 | 400mg | |||
| DEXTROSE | ORAL | PASTILLE | IY9XDZ35W2 | 826mg | |||
| DEXTROSE | ORAL | POWDER, FOR SOLUTION | IY9XDZ35W2 | NA | |||
| DEXTROSE | ORAL | SOLUTION | IY9XDZ35W2 | 2489mg/5ml | |||
| DEXTROSE | ORAL | SYRUP | IY9XDZ35W2 | 620mg | |||
| DEXTROSE | ORAL | TABLET | IY9XDZ35W2 | 183.66mg | |||
| DEXTROSE | ORAL | TABLET, CHEWABLE | IY9XDZ35W2 | 642.76mg | |||
| DEXTROSE | ORAL | TABLET, COATED | IY9XDZ35W2 | 132mg | |||
| DEXTROSE | ORAL | TABLET, DELAYED RELEASE | IY9XDZ35W2 | NA | |||
| DEXTROSE | ORAL | TABLET, EXTENDED RELEASE | IY9XDZ35W2 | 103.95mg | |||
| DEXTROSE | ORAL | TROCHE | IY9XDZ35W2 | 903.5mg | |||
| DEXTROSE | SUBLINGUAL | TABLET | IY9XDZ35W2 | 115.78mg | |||
| DEXTROSE | VAGINAL | POWDER | IY9XDZ35W2 | 430mg | |||
| DEXTROSE MONOHYDRATE | INTRAMUSCULAR | INJECTION, EMULSION | 77938637 | LX22YL083G | 188mg | ||
| DEXTROSE MONOHYDRATE | INTRAVENOUS | INJECTION | 77938637 | LX22YL083G | 30144mg | ||
| DEXTROSE MONOHYDRATE | INTRAVENOUS | INJECTION, EMULSION | 77938637 | LX22YL083G | 188mg | ||
| DEXTROSE MONOHYDRATE | INTRAVENOUS | INJECTION, SOLUTION | 77938637 | LX22YL083G | 30144mg | ||
| DEXTROSE MONOHYDRATE | NASAL | SPRAY, METERED | 77938637 | LX22YL083G | 20mg | ||
| DEXTROSE MONOHYDRATE | ORAL | CAPSULE | 77938637 | LX22YL083G | 345mg | ||
| DEXTROSE MONOHYDRATE | ORAL | TABLET | 77938637 | LX22YL083G | 11mg | ||
| DEXTROSE MONOHYDRATE | ORAL | TABLET, EXTENDED RELEASE | 77938637 | LX22YL083G | 92mg | ||
| DEXTROSE MONOHYDRATE | SUBCUTANEOUS | INJECTION, EMULSION | 77938637 | LX22YL083G | 188mg | ||
| DIACETYLATED MONOGLYCERIDES | ORAL | CAPSULE, DELAYED RELEASE | 8029923 | 5Z17386USF | 4mg | ||
| DIACETYLATED MONOGLYCERIDES | ORAL | CAPSULE, EXTENDED RELEASE | 8029923 | 5Z17386USF | 8mg | ||
| DIACETYLATED MONOGLYCERIDES | ORAL | SOLUTION | 8029923 | 5Z17386USF | 240mg/1ml | ||
| DIACETYLATED MONOGLYCERIDES | ORAL | TABLET | 8029923 | 5Z17386USF | 189mg | ||
| DIACETYLATED MONOGLYCERIDES | ORAL | TABLET, COATED | 8029923 | 5Z17386USF | 0.63mg | ||
| DIACETYLATED MONOGLYCERIDES | ORAL | TABLET, DELAYED RELEASE | 8029923 | 5Z17386USF | 51mg | ||
| DIACETYLATED MONOGLYCERIDES | ORAL | TABLET, EXTENDED RELEASE | 8029923 | 5Z17386USF | 2.48mg | ||
| DIACETYLATED MONOGLYCERIDES | ORAL | TABLET, FILM COATED | 8029923 | 5Z17386USF | 12mg | ||
| DIATOMACEOUS EARTH | ORAL | CAPSULE | 61790532 | 2RF6EJ0M85 | 3.4mg | ||
| DIATOMACEOUS EARTH | ORAL | CAPSULE, EXTENDED RELEASE | 61790532 | 2RF6EJ0M85 | 5mg | ||
| DIATOMACEOUS EARTH | ORAL | CONCENTRATE | 61790532 | 2RF6EJ0M85 | NA | ||
| DIATOMACEOUS EARTH | ORAL | ELIXIR | 61790532 | 2RF6EJ0M85 | NA | ||
| DIATOMACEOUS EARTH | ORAL | SYRUP | 61790532 | 2RF6EJ0M85 | NA | ||
| DIATOMACEOUS EARTH | ORAL | TABLET | 61790532 | 2RF6EJ0M85 | 88mg | ||
| DIATOMACEOUS EARTH | ORAL | TABLET, CHEWABLE | 61790532 | 2RF6EJ0M85 | 2mg | ||
| DIATOMACEOUS EARTH | ORAL | TABLET, COATED | 61790532 | 2RF6EJ0M85 | 7.2mg | ||
| DIATOMACEOUS EARTH | ORAL | TABLET, EXTENDED RELEASE | 61790532 | 2RF6EJ0M85 | 5mg | ||
| DIATOMACEOUS EARTH | TOPICAL | SOAP | 61790532 | 2RF6EJ0M85 | 0.27%w/w | ||
| DIATRIZOIC ACID | INTRAMUSCULAR | INJECTION | 117964 | 5UVC90J1LK | ADJ PH | ||
| DIATRIZOIC ACID | INTRAVASCULAR | INJECTION | 117964 | 5UVC90J1LK | ADJ PH | ||
| DIATRIZOIC ACID | INTRAVENOUS | INJECTION | 117964 | 5UVC90J1LK | ADJ PH | ||
| DIATRIZOIC ACID | URETERAL | SOLUTION | 117964 | 5UVC90J1LK | ADJ PH | ||
| DIAZOLIDINYL UREA | TOPICAL | CREAM | 78491028 | H5RIZ3MPW4 | 0.25%w/w | ||
| DIAZOLIDINYL UREA | TOPICAL | LOTION | 78491028 | H5RIZ3MPW4 | NA | ||
| DIAZOLIDINYL UREA | TOPICAL | OINTMENT | 78491028 | H5RIZ3MPW4 | 0.1%w/w | ||
| DIBASIC CALCIUM PHOSPHATE DIHYDRATE | DENTAL | PASTE, DENTIFRICE | 7789777 | O7TSZ97GEP | 51%w/w | ||
| DIBASIC CALCIUM PHOSPHATE DIHYDRATE | ORAL | CAPSULE | 7789777 | O7TSZ97GEP | 400mg | ||
| DIBASIC CALCIUM PHOSPHATE DIHYDRATE | ORAL | CAPSULE, EXTENDED RELEASE | 7789777 | O7TSZ97GEP | 51mg | ||
| DIBASIC CALCIUM PHOSPHATE DIHYDRATE | ORAL | TABLET | 7789777 | O7TSZ97GEP | 2442mg | ||
| DIBASIC CALCIUM PHOSPHATE DIHYDRATE | ORAL | TABLET, CHEWABLE | 7789777 | O7TSZ97GEP | 53mg | ||
| DIBASIC CALCIUM PHOSPHATE DIHYDRATE | ORAL | TABLET, COATED | 7789777 | O7TSZ97GEP | 488.7mg | ||
| DIBASIC CALCIUM PHOSPHATE DIHYDRATE | ORAL | TABLET, DELAYED RELEASE | 7789777 | O7TSZ97GEP | 44mg | ||
| DIBASIC CALCIUM PHOSPHATE DIHYDRATE | ORAL | TABLET, EXTENDED RELEASE | 7789777 | O7TSZ97GEP | 1036mg | ||
| DIBASIC CALCIUM PHOSPHATE DIHYDRATE | ORAL | TABLET, FILM COATED | 7789777 | O7TSZ97GEP | 953mg | ||
| DIBASIC CALCIUM PHOSPHATE DIHYDRATE | ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 7789777 | O7TSZ97GEP | 258.45mg | ||
| DIBASIC POTASSIUM PHOSPHATE | INTRA-ARTICULAR | INJECTION | 7758114 | CI71S98N1Z | 0.6%w/v | ||
| DIBASIC POTASSIUM PHOSPHATE | INTRAMUSCULAR | INJECTION | 7758114 | CI71S98N1Z | 0.6%w/v | ||
| DIBASIC POTASSIUM PHOSPHATE | ORAL | CAPSULE | 7758114 | CI71S98N1Z | 30mg | ||
| DIBASIC POTASSIUM PHOSPHATE | ORAL | SOLUTION | 7758114 | CI71S98N1Z | 890mg | Y | |
| DIBASIC POTASSIUM PHOSPHATE | ORAL | SUSPENSION | 7758114 | CI71S98N1Z | 24mg | ||
| DIBASIC POTASSIUM PHOSPHATE | ORAL | SYRUP | 7758114 | CI71S98N1Z | 22mg/5ml | ||
| DIBASIC POTASSIUM PHOSPHATE | ORAL | TABLET | 7758114 | CI71S98N1Z | NA | ||
| DIBASIC POTASSIUM PHOSPHATE | SUBCUTANEOUS | INJECTION | 7758114 | CI71S98N1Z | 13.6mg | ||
| DIBUTYL SEBACATE | ORAL | CAPSULE | 109433 | 4W5IH7FLNY | 15mg | ||
| DIBUTYL SEBACATE | ORAL | CAPSULE, DELAYED RELEASE | 109433 | 4W5IH7FLNY | 20mg | ||
| DIBUTYL SEBACATE | ORAL | CAPSULE, EXTENDED RELEASE | 109433 | 4W5IH7FLNY | 278mg | ||
| DIBUTYL SEBACATE | ORAL | GRANULE, DELAYED RELEASE | 109433 | 4W5IH7FLNY | 43.2mg | ||
| DIBUTYL SEBACATE | ORAL | PELLET | 109433 | 4W5IH7FLNY | 4mg | ||
| DIBUTYL SEBACATE | ORAL | SUSPENSION, EXTENDED RELEASE | 109433 | 4W5IH7FLNY | 37mg | ||
| DIBUTYL SEBACATE | ORAL | TABLET | 109433 | 4W5IH7FLNY | 23mg | ||
| DIBUTYL SEBACATE | ORAL | TABLET, COATED | 109433 | 4W5IH7FLNY | 24mg | ||
| DIBUTYL SEBACATE | ORAL | TABLET, EXTENDED RELEASE | 109433 | 4W5IH7FLNY | 59mg | ||
| DIBUTYL SEBACATE | ORAL | TABLET, FILM COATED | 109433 | 4W5IH7FLNY | NA | ||
| DICHLOROBENZYL ALCOHOL | TOPICAL | CREAM | 1777828 | 1NKX3648J9 | 0.1%w/w | ||
| DICHLORODIFLUOROMETHANE | INTRAPLEURAL | AEROSOL, METERED | 75718 | OFM06SG1KO | 26%w/v | ||
| DICHLORODIFLUOROMETHANE | NASAL | AEROSOL, METERED | 75718 | OFM06SG1KO | NA | ||
| DICHLORODIFLUOROMETHANE | RECTAL | AEROSOL, METERED | 75718 | OFM06SG1KO | NA | ||
| DICHLORODIFLUOROMETHANE | RESPIRATORY (INHALATION) | AEROSOL, METERED | 75718 | OFM06SG1KO | 98.7%w/w | ||
| DICHLORODIFLUOROMETHANE | RESPIRATORY (INHALATION) | AEROSOL, SPRAY | 75718 | OFM06SG1KO | 31.8%w/w | ||
| DICHLORODIFLUOROMETHANE | TOPICAL | AEROSOL, FOAM | 75718 | OFM06SG1KO | 8%w/w | ||
| DICHLORODIFLUOROMETHANE | TOPICAL | AEROSOL, POWDER | 75718 | OFM06SG1KO | NA | ||
| DICHLORODIFLUOROMETHANE | TOPICAL | AEROSOL, SPRAY | 75718 | OFM06SG1KO | 26%w/w | ||
| DICHLORODIFLUOROMETHANE | VAGINAL | AEROSOL, FOAM | 75718 | OFM06SG1KO | 20%w/w | ||
| DICHLOROTETRAFLUOROETHANE | RECTAL | AEROSOL, METERED | 76142 | 6B5VVT93AR | NA | ||
| DICHLOROTETRAFLUOROETHANE | RESPIRATORY (INHALATION) | AEROSOL, METERED | 76142 | 6B5VVT93AR | 51.12%w/w | ||
| DICHLOROTETRAFLUOROETHANE | RESPIRATORY (INHALATION) | AEROSOL, SPRAY | 76142 | 6B5VVT93AR | 67.2%w/w | ||
| DICHLOROTETRAFLUOROETHANE | TOPICAL | AEROSOL, FOAM | 76142 | 6B5VVT93AR | NA | ||
| DICHLOROTETRAFLUOROETHANE | VAGINAL | AEROSOL, FOAM | 76142 | 6B5VVT93AR | 85%w/w | ||
| DICHLOROTETRAFLUOROETHANE | VAGINAL | AEROSOL, SPRAY | 76142 | 6B5VVT93AR | NA | ||
| DIETHANOLAMINE | INTRAVENOUS | INJECTION | 111422 | AZE05TDV2V | 1.5%w/v | ||
| DIETHANOLAMINE | TOPICAL | CREAM | 111422 | AZE05TDV2V | 0.3%w/w | ||
| DIETHYL PHTHALATE | ORAL | CAPSULE | 84662 | UF064M00AF | 9mg | ||
| DIETHYL PHTHALATE | ORAL | CAPSULE, COATED PELLETS | 84662 | UF064M00AF | 6.8mg | ||
| DIETHYL PHTHALATE | ORAL | CAPSULE, DELAYED RELEASE | 84662 | UF064M00AF | 12mg | ||
| DIETHYL PHTHALATE | ORAL | CAPSULE, EXTENDED RELEASE | 84662 | UF064M00AF | 172mg | ||
| DIETHYL PHTHALATE | ORAL | TABLET | 84662 | UF064M00AF | 6mg | ||
| DIETHYL PHTHALATE | ORAL | TABLET, CHEWABLE | 84662 | UF064M00AF | 6mg | ||
| DIETHYL PHTHALATE | ORAL | TABLET, COATED | 84662 | UF064M00AF | 2.8mg | ||
| DIETHYL PHTHALATE | ORAL | TABLET, DELAYED RELEASE | 84662 | UF064M00AF | 131mg | Y | |
| DIETHYL PHTHALATE | ORAL | TABLET, EXTENDED RELEASE | 84662 | UF064M00AF | 43mg | ||
| DIETHYL PHTHALATE | ORAL | TABLET, FILM COATED | 84662 | UF064M00AF | 4mg | ||
| DIETHYL SEBACATE | TOPICAL | LOTION | 110407 | I41B9FJK6V | 2.97%w/w | ||
| DIETHYL SEBACATE | TOPICAL | SOLUTION | 110407 | I41B9FJK6V | 24%w/w | ||
| DIETHYLENE GLYCOL MONOETHYL ETHER | TOPICAL | CREAM | 111900 | A1A1I8X02B | 1290mg | ||
| DIETHYLENE GLYCOL MONOETHYL ETHER | TOPICAL | GEL | 111900 | A1A1I8X02B | 1500mg | ||
| DIETHYLENE GLYCOL MONOETHYL ETHER | TOPICAL | LOTION | 111900 | A1A1I8X02B | 714mg | ||
| DIETHYLENE GLYCOL MONOETHYL ETHER | TOPICAL | OINTMENT | 111900 | A1A1I8X02B | 5%w/w | ||
| DIETHYLENE GLYCOL MONOETHYL ETHER | TRANSDERMAL | GEL | 111900 | A1A1I8X02B | 5%w/w | ||
| DIETHYLENE GLYCOL MONOETHYL ETHER | TRANSDERMAL | SYSTEM | 111900 | A1A1I8X02B | 430mg | ||
| DIHYDROXYALUMINUM AMINOACETATE | ORAL | TABLET | 41354487 | DO250MG0W6 | NA | ||
| DIHYDROXYALUMINUM AMINOACETATE | TOPICAL | SYSTEM | 41354487 | DO250MG0W6 | 210mg | ||
| DIHYDROXYALUMINUM SODIUM CARBONATE | ORAL | TABLET | 16482556 | 84H8Z9550J | 7.2mg | ||
| DIHYDROXYALUMINUM SODIUM CARBONATE | ORAL | TABLET, CHEWABLE | 16482556 | 84H8Z9550J | NA | ||
| DIISOPROPANOLAMINE | TOPICAL | CREAM | 110974 | 0W44HYL8T5 | 10mg | ||
| DIISOPROPANOLAMINE | TOPICAL | GEL | 110974 | 0W44HYL8T5 | 1.5%w/w | ||
| DIISOPROPANOLAMINE | TOPICAL | SOLUTION | 110974 | 0W44HYL8T5 | ADJ PH | ||
| DIISOPROPYL ADIPATE | TOPICAL | AEROSOL, FOAM | 6938949 | P7E6YFV72X | 5%w/w | ||
| DIISOPROPYL ADIPATE | TOPICAL | CREAM | 6938949 | P7E6YFV72X | 170mg | Y | |
| DIISOPROPYL ADIPATE | TOPICAL | GEL | 6938949 | P7E6YFV72X | 150mg | ||
| DIISOPROPYL ADIPATE | TOPICAL | LOTION | 6938949 | P7E6YFV72X | 250mg | ||
| DIISOPROPYL ADIPATE | TOPICAL | SOLUTION | 6938949 | P7E6YFV72X | 10.88%w/v | ||
| DIISOPROPYL ADIPATE | TOPICAL | SPRAY | 6938949 | P7E6YFV72X | 360mg | ||
| DIISOPROPYL ADIPATE | TRANSDERMAL | GEL | 6938949 | P7E6YFV72X | 1.5%w/w | ||
| DIISOPROPYLBENZOTHIAZYL-2-SULFENAMIDE | ORAL | TABLET | 95294 | 3LH1P5MUK0 | 105mg | ||
| DIISOPROPYLBENZOTHIAZYL-2-SULFENAMIDE | ORAL | TABLET, CHEWABLE | 95294 | 3LH1P5MUK0 | 151.98mg | ||
| DIMETHICONE 100 | ORAL | TABLET, FILM COATED | 9006659 | RO266O364U | 10mg | ||
| DIMETHICONE 100 | TOPICAL | GEL | 9006659 | RO266O364U | 0.1%w/w | ||
| DIMETHICONE 20 | TOPICAL | CREAM | 9006659 | H8YMB5QY0D | 5mg | ||
| DIMETHICONE 350 | ORAL | CAPSULE | 9006659 | 2Y53S6ATLU | 3.7mg | ||
| DIMETHICONE 350 | ORAL | CAPSULE, EXTENDED RELEASE | 9006659 | 2Y53S6ATLU | 0.11mg | ||
| DIMETHICONE 350 | TOPICAL | CREAM | 9006659 | 2Y53S6ATLU | 114mg | ||
| DIMETHICONE 350 | TOPICAL | LOTION | 9006659 | 2Y53S6ATLU | 1%w/w | ||
| DIMETHICONE 350 | TOPICAL | SOLUTION | 9006659 | 2Y53S6ATLU | 0.5%w/w | ||
| DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER (40/60 W/W; 1000000 PA.S) | ORAL | TABLET, EXTENDED RELEASE | 83D19O7250 | 1.14mg | |||
| DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER (40/60 W/W; 1000000 PA.S) | TRANSDERMAL | FILM | 83D19O7250 | 71mg | |||
| DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER (40/60 W/W; 1000000 PA.S) | TRANSDERMAL | FILM, EXTENDED RELEASE | 83D19O7250 | 164mg | |||
| DIMETHICONOL/TRIMETHYLSILOXYSILICATE CROSSPOLYMER (40/60 W/W; 1000000 PA.S) | TRANSDERMAL | SYSTEM | 83D19O7250 | 61.3mg | |||
| DIMETHOXANE | TOPICAL | EMULSION | 828002 | S0859MSI8I | 0.08%w/w | ||
| DIMETHYL ISOSORBIDE | TOPICAL | AEROSOL, FOAM | 5306854 | SA6A6V432S | 5.44%w/w | ||
| DIMETHYL ISOSORBIDE | TOPICAL | CREAM | 5306854 | SA6A6V432S | 15%w/w | ||
| DIMETHYL SULFOXIDE | INTRAVENOUS | INJECTION, POWDER, FOR SUSPENSION | 67685 | YOW8V9698H | NA | ||
| DIMETHYL SULFOXIDE | SUBCUTANEOUS | IMPLANT | 67685 | YOW8V9698H | 104mg | ||
| DIMETHYL SULFOXIDE | TOPICAL | LOTION | 67685 | YOW8V9698H | 45.5%w/w | ||
| DIMETHYL SULFOXIDE | TOPICAL | SOLUTION | 67685 | YOW8V9698H | 8008mg | Y | |
| DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER | ORAL | CAPSULE | 24938167 | 905HNO1SIH | 4.52mg | ||
| DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER | ORAL | CAPSULE, EXTENDED RELEASE | 24938167 | 905HNO1SIH | 67mg | ||
| DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER | ORAL | PELLET | 24938167 | 905HNO1SIH | 55mg | ||
| DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER | ORAL | SUSPENSION | 24938167 | 905HNO1SIH | 255mg | ||
| DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER | ORAL | TABLET | 24938167 | 905HNO1SIH | 120mg | ||
| DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER | ORAL | TABLET, CHEWABLE | 24938167 | 905HNO1SIH | 4.57mg | ||
| DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER | ORAL | TABLET, COATED | 24938167 | 905HNO1SIH | 160mg | ||
| DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER | ORAL | TABLET, DELAYED RELEASE | 24938167 | 905HNO1SIH | 4mg | ||
| DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER | ORAL | TABLET, EXTENDED RELEASE | 24938167 | 905HNO1SIH | 56mg | ||
| DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER | ORAL | TABLET, FILM COATED | 24938167 | 905HNO1SIH | 100mg | ||
| DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER | ORAL | TABLET, ORALLY DISINTEGRATING | 24938167 | 905HNO1SIH | 181mg | ||
| DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER | TRANSDERMAL | FILM, EXTENDED RELEASE | 24938167 | 905HNO1SIH | NA | ||
| DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER | TRANSDERMAL | SYSTEM | 24938167 | 905HNO1SIH | 18mg | ||
| DINOSEB-AMMONIUM | TOPICAL | SPONGE | 6365839 | B5TNV5E10B | NA | ||
| DIPALMITOYLPHOSPHATIDYLGLYCEROL, DL- | INFILTRATION | INJECTABLE, LIPOSOMAL | 4537773 | VA9U6BR3SB | 0.09%w/v | ||
| DIPALMITOYLPHOSPHATIDYLGLYCEROL, DL- | INTRAVENOUS | INJECTION, SUSPENSION | 4537773 | VA9U6BR3SB | NA | ||
| DIPROPYLENE GLYCOL | BUCCAL | SYSTEM | 25265718 | E107L85C40 | 29.9mg | ||
| DIPROPYLENE GLYCOL | TRANSDERMAL | FILM | 25265718 | E107L85C40 | 5.37mg | ||
| DIPROPYLENE GLYCOL | TRANSDERMAL | FILM, EXTENDED RELEASE | 25265718 | E107L85C40 | 296mg | ||
| DIPROPYLENE GLYCOL | TRANSDERMAL | SYSTEM | 25265718 | E107L85C40 | 6mg | ||
| DISODIUM CITRATE SESQUIHYDRATE | INTRAVENOUS | INJECTION | 6132054 | CZ1032CEKR | 0.18%w/v | ||
| DISODIUM COCOAMPHODIACETATE | TOPICAL | SHAMPOO, SUSPENSION | 68650395 | 18L9G3U51M | 5%w/v | ||
| DISODIUM HYDROGEN CITRATE | INTRAVENOUS | INJECTION | 144332 | 6FO62KCQ7A | 0.09%w/v | ||
| DISODIUM LAURETH SULFOSUCCINATE | TOPICAL | GEL | 58450525 | D6DH1DTN7E | 0.04%w/w | ||
| DISODIUM LAURETH SULFOSUCCINATE | TOPICAL | SHAMPOO | 58450525 | D6DH1DTN7E | 15%w/w | ||
| DISODIUM LAURYL SULFOSUCCINATE | TOPICAL | GEL | 26838051 | P160Q81342 | 0.04%w/w | ||
| DISODIUM LAURYL SULFOSUCCINATE | TOPICAL | SHAMPOO | 26838051 | P160Q81342 | 15%w/w | ||
| DISTEAROYLPHOSPHATIDYLCHOLINE, DL- | INTRAVENOUS | INJECTION, POWDER, FOR SUSPENSION | 4539702 | EAG959U971 | 2.27%w/v | ||
| DISTEAROYLPHOSPHATIDYLCHOLINE, DL- | INTRAVENOUS | INJECTION, SUSPENSION | 4539702 | EAG959U971 | NA | ||
| DISTEAROYLPHOSPHATIDYLGLYCEROL, DL- | INTRAVENOUS | INJECTION, POWDER, FOR SUSPENSION | 4537784 | 4271ZA8WXO | 0.66%w/v | ||
| DL-LACTIDE AND GLYCOLIDE (50:50) COPOLYMER 12000 ACID | ENDOSINUSIAL | IMPLANT | 26780507 | WE369X5600 | 1.35mg | ||
| DL-LACTIDE AND GLYCOLIDE (50:50) COPOLYMER 12000 ACID | INTRAVITREAL | IMPLANT | 26780507 | WE369X5600 | 116mg | ||
| DL-LACTIDE AND GLYCOLIDE (50:50) COPOLYMER 12000 ACID | INTRAVITREAL | INJECTION | 26780507 | WE369X5600 | 116mg | ||
| DL-LACTIDE AND GLYCOLIDE (50:50) COPOLYMER 12000 ACID | SUBCUTANEOUS | INJECTION, SOLUTION | 26780507 | WE369X5600 | 533mg | ||
| DL-LACTIDE AND GLYCOLIDE (75:25) COPOLYMER 20000 ACID | INTRAMUSCULAR | INJECTION | 26780507 | 58X445TH30 | 145mg | ||
| DL-LACTIDE AND GLYCOLIDE (75:25) COPOLYMER 20000 ACID | INTRAMUSCULAR | INJECTION, POWDER, FOR SUSPENSION | 26780507 | 58X445TH30 | 11mg | ||
| DMDM HYDANTOIN | TOPICAL | LOTION | 6440580 | BYR0546TOW | 0.4%w/w | ||
| DOCOSANOL | TOPICAL | AEROSOL, FOAM | 661198 | 9G1OE216XY | 1.1%w/w | ||
| DOCOSANOL | TOPICAL | SOLUTION | 661198 | 9G1OE216XY | 1.1%w/w | ||
| DOCUSATE SODIUM | INTRAMUSCULAR | INJECTION | 577117 | F05Q2T2JA0 | 0.02%w/v | ||
| DOCUSATE SODIUM | ORAL | CAPSULE | 577117 | F05Q2T2JA0 | 8.2mg | ||
| DOCUSATE SODIUM | ORAL | CAPSULE, EXTENDED RELEASE | 577117 | F05Q2T2JA0 | NA | ||
| DOCUSATE SODIUM | ORAL | GRANULE, FOR SUSPENSION, EXTENDED RELEASE | 577117 | F05Q2T2JA0 | NA | ||
| DOCUSATE SODIUM | ORAL | SUSPENSION | 577117 | F05Q2T2JA0 | 48mg | ||
| DOCUSATE SODIUM | ORAL | SUSPENSION, EXTENDED RELEASE | 577117 | F05Q2T2JA0 | 0.77mg | ||
| DOCUSATE SODIUM | ORAL | TABLET | 577117 | F05Q2T2JA0 | 50mg | ||
| DOCUSATE SODIUM | ORAL | TABLET, COATED | 577117 | F05Q2T2JA0 | 1mg | ||
| DOCUSATE SODIUM | ORAL | TABLET, FILM COATED | 577117 | F05Q2T2JA0 | 6mg | ||
| DOCUSATE SODIUM | TOPICAL | GEL | 577117 | F05Q2T2JA0 | 0.3%w/w | ||
| DOCUSATE SODIUM | TOPICAL | SHAMPOO | 577117 | F05Q2T2JA0 | 2%w/w | ||
| DOCUSATE SODIUM/SODIUM BENZOATE | ORAL | CAPSULE | 121183106 | 656HXR6YXN | 85mg | ||
| DOCUSATE SODIUM/SODIUM BENZOATE | ORAL | CAPSULE, EXTENDED RELEASE | 121183106 | 656HXR6YXN | 0.14mg | ||
| DOCUSATE SODIUM/SODIUM BENZOATE | ORAL | TABLET | 121183106 | 656HXR6YXN | 48mg | ||
| DOCUSATE SODIUM/SODIUM BENZOATE | ORAL | TABLET, FILM COATED | 121183106 | 656HXR6YXN | 6mg | Y | |
| DRI KLEAR 042 | ORAL | TABLET | NA | 18mg | |||
| DRI KLEAR 042 | ORAL | TABLET, COATED | NA | 10mg | |||
| DRI KLEAR 042 | ORAL | TABLET, FILM COATED | NA | 5.67mg | |||
| DURO-TAK 280-2516 | TRANSDERMAL | FILM, EXTENDED RELEASE | NA | NA | |||
| DURO-TAK 280-2516 | TRANSDERMAL | SYSTEM | NA | 45mg | |||
| DURO-TAK 87-2070 | TRANSDERMAL | FILM, EXTENDED RELEASE | NA | NA | |||
| DURO-TAK 87-2070 | TRANSDERMAL | SYSTEM | NA | NA | |||
| DURO-TAK 87-2194 | TRANSDERMAL | FILM, EXTENDED RELEASE | NA | 208.28mg | |||
| DURO-TAK 87-2287 | TRANSDERMAL | FILM | NA | 537.7mg | |||
| DURO-TAK 87-2287 | TRANSDERMAL | FILM, EXTENDED RELEASE | NA | 121.1mg | |||
| DURO-TAK 87-2287 | TRANSDERMAL | SYSTEM | NA | 11.39mg | |||
| DURO-TAK 87-2296 | TRANSDERMAL | SYSTEM | NA | 172mg | |||
| DURO-TAK 87-2888 | TRANSDERMAL | SYSTEM | NA | 175.9mg | |||
| DURO-TAK 87-2979 | TRANSDERMAL | FILM, EXTENDED RELEASE | NA | NA | |||
| DURO-TAK 87-2979 | TRANSDERMAL | SYSTEM | NA | 96.97mg | |||
| DYE BLACK LB-1171 | ORAL | TABLET | NA | 1.55mg | |||
| DYE BLACK LB-442 | ORAL | TABLET | NA | 0.33mg | |||
| DYE BLACK LB-9972 | ORAL | TABLET | NA | 0.19mg | |||
| DYE BLUE LAKE BLEND LB-332 | ORAL | CAPSULE | NA | 0.56mg | |||
| DYE BLUE LAKE BLEND LB-332 | ORAL | TABLET | NA | 0.11mg | |||
| DYE BLUE LAKOLENE | ORAL | TABLET | NA | 0.12mg | |||
| DYE BROWN LAKE BLEND | BUCCAL | GUM, CHEWING | NA | 3mg | |||
| DYE BROWN LAKE BLEND | ORAL | TABLET | NA | 0.26mg | |||
| DYE BROWN LB-464 | ORAL | TABLET | NA | 1.3mg | |||
| DYE CARAMEL ACID PROOF 100 | ORAL | ELIXIR | NA | 0.05mg/5ml | |||
| DYE CARAMEL ACID PROOF 100 | ORAL | SYRUP | NA | NA | |||
| DYE CHROMA-TONE | ORAL | CAPSULE | NA | 59mg | |||
| DYE CHROMA-TONE | ORAL | CAPSULE, DELAYED RELEASE | NA | 29.6mg | |||
| DYE CHROMA-TONE | ORAL | TABLET, FILM COATED | NA | 1.53mg | |||
| DYE DC RED LAKE | ORAL | TABLET | NA | 2.4mg | |||
| DYE DC RED LB NO. 9570 | ORAL | TABLET | NA | 0.85mg | |||
| DYE FDC BROWN R LB-56069 | BUCCAL | GUM, CHEWING | NA | 0.14mg | |||
| DYE FDC BROWN R LB-56069 | ORAL | TABLET | NA | 0.2mg | |||
| DYE FDC GREEN LB-1174 | ORAL | TABLET | NA | 1mg | Y | ||
| DYE FDC GREEN LB-3323 | ORAL | TABLET | NA | 1.65mg | |||
| DYE GRAY NO. 2982 | ORAL | CAPSULE | NA | NA | |||
| DYE GREEN AL LB-265 | ORAL | TABLET | NA | 0.64mg | |||
| DYE GREEN ALUMINUM LB | ORAL | TABLET | NA | 8mg | |||
| DYE GREEN LAKE BLEND LB-1236 | ORAL | TABLET | NA | 0.35mg | |||
| DYE GREEN LAKE BLEND LB-1441 | ORAL | TABLET | NA | 1.32mg | |||
| DYE GREEN LAKE BLEND LB-333 | ORAL | CAPSULE | NA | 6mg | |||
| DYE GREEN LAKE BLEND LB-333 | ORAL | TABLET | NA | 0.11mg | |||
| DYE GREEN LB | ORAL | TABLET | NA | 0.4mg | |||
| DYE GREEN LB-279 | ORAL | TABLET | NA | 2mg | |||
| DYE GREEN LB-482 | ORAL | TABLET | NA | 1.27mg | |||
| DYE GREEN LB-555 | ORAL | TABLET | NA | 0.44mg | |||
| DYE GREEN LB-820 | ORAL | TABLET | NA | 2mg | |||
| DYE GREEN LB-883 | ORAL | TABLET | NA | 0.6mg | |||
| DYE GREEN PB-1543 | ORAL | TABLET | NA | 1.2mg | |||
| DYE MINT GREEN | ORAL | TABLET | NA | 0.01mg | |||
| DYE MINT GREEN | ORAL | TABLET, CHEWABLE | NA | 0.08mg | |||
| DYE MINT GREEN | ORAL | TABLET, EXTENDED RELEASE | NA | 0.06mg | |||
| DYE OCHRE 3506 | ORAL | TABLET | NA | 0.76mg | |||
| DYE OCHRE 3506 | ORAL | TABLET, COATED | NA | 0.29mg | |||
| DYE ORANGE LB-1387 | ORAL | TABLET | NA | 0.5mg | |||
| DYE ORANGE LB-1387 | ORAL | TABLET, EXTENDED RELEASE | NA | 0.4mg | |||
| DYE ORANGE PB-2148 | ORAL | TABLET | NA | 1mg | |||
| DYE PINK | ORAL | CAPSULE | NA | NA | |||
| DYE PINK | ORAL | TABLET | NA | 0.3mg | |||
| DYE PINK | ORAL | TABLET, DELAYED RELEASE | NA | 7.93mg | |||
| DYE PURPLE LB-1902 | ORAL | TABLET, EXTENDED RELEASE | NA | 0.8mg | |||
| DYE PURPLE LB-562 | ORAL | TABLET | NA | 0.81mg | |||
| DYE RED PB-1595 | ORAL | TABLET | NA | 0.8mg | |||
| DYE TAN PB-1388 | ORAL | TABLET | NA | 0.05mg | |||
| DYE TAN PB-1388 | ORAL | TABLET, FILM COATED | NA | 0.75mg | |||
| DYE WHITE COATERIC YPA-6-7089 | ORAL | TABLET, DELAYED RELEASE | NA | NA | |||
| DYE WILD CHERRY 7598 | ORAL | SYRUP | NA | 0.18mg/5ml | |||
| DYE YELLOW LB 9706 | ORAL | TABLET | NA | 0.44mg | |||
| DYE YELLOW PB-1381 | ORAL | TABLET | NA | 0.2mg |
FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections: IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly
Data Through: January 1, 2023
Database Last Updated: January 26, 2023